EconPapers    
Economics at your fingertips  
 

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Constanze Depp (), Ting Sun, Andrew Octavian Sasmita, Lena Spieth, Stefan A. Berghoff, Taisiia Nazarenko, Katharina Overhoff, Agnes A. Steixner-Kumar, Swati Subramanian, Sahab Arinrad, Torben Ruhwedel, Wiebke Möbius, Sandra Göbbels, Gesine Saher, Hauke B. Werner, Alkmini Damkou, Silvia Zampar, Oliver Wirths, Maik Thalmann, Mikael Simons, Takashi Saito, Takaomi Saido, Dilja Krueger-Burg, Riki Kawaguchi, Michael Willem, Christian Haass, Daniel Geschwind, Hannelore Ehrenreich, Ruth Stassart and Klaus-Armin Nave ()
Additional contact information
Constanze Depp: Max Planck Institute for Multidisciplinary Sciences
Ting Sun: Max Planck Institute for Multidisciplinary Sciences
Andrew Octavian Sasmita: Max Planck Institute for Multidisciplinary Sciences
Lena Spieth: Max Planck Institute for Multidisciplinary Sciences
Stefan A. Berghoff: Max Planck Institute for Multidisciplinary Sciences
Taisiia Nazarenko: Max Planck Institute for Multidisciplinary Sciences
Katharina Overhoff: Max Planck Institute for Multidisciplinary Sciences
Agnes A. Steixner-Kumar: Max Planck Institute for Multidisciplinary Sciences
Swati Subramanian: Max Planck Institute for Multidisciplinary Sciences
Sahab Arinrad: Max Planck Institute for Multidisciplinary Sciences
Torben Ruhwedel: Max Planck Institute for Multidisciplinary Sciences
Wiebke Möbius: Max Planck Institute for Multidisciplinary Sciences
Sandra Göbbels: Max Planck Institute for Multidisciplinary Sciences
Gesine Saher: Max Planck Institute for Multidisciplinary Sciences
Hauke B. Werner: Max Planck Institute for Multidisciplinary Sciences
Alkmini Damkou: Technical University Munich
Silvia Zampar: University Medical Center, Georg-August University
Oliver Wirths: University Medical Center, Georg-August University
Maik Thalmann: Georg-August University
Mikael Simons: Technical University Munich
Takashi Saito: Nagoya City University Graduate School of Medical Sciences
Takaomi Saido: RIKEN Center for Brain Science
Dilja Krueger-Burg: University Medical Center, Georg-August University
Riki Kawaguchi: University of California Los Angeles
Michael Willem: German Center for Neurodegenerative Diseases
Christian Haass: German Center for Neurodegenerative Diseases
Daniel Geschwind: University of California Los Angeles
Hannelore Ehrenreich: Max Planck Institute for Multidisciplinary Sciences
Ruth Stassart: Max Planck Institute for Multidisciplinary Sciences
Klaus-Armin Nave: Max Planck Institute for Multidisciplinary Sciences

Nature, 2023, vol. 618, issue 7964, 349-357

Abstract: Abstract The incidence of Alzheimer’s disease (AD), the leading cause of dementia, increases rapidly with age, but why age constitutes the main risk factor is still poorly understood. Brain ageing affects oligodendrocytes and the structural integrity of myelin sheaths1, the latter of which is associated with secondary neuroinflammation2,3. As oligodendrocytes support axonal energy metabolism and neuronal health4–7, we hypothesized that loss of myelin integrity could be an upstream risk factor for neuronal amyloid-β (Aβ) deposition, the central neuropathological hallmark of AD. Here we identify genetic pathways of myelin dysfunction and demyelinating injuries as potent drivers of amyloid deposition in mouse models of AD. Mechanistically, myelin dysfunction causes the accumulation of the Aβ-producing machinery within axonal swellings and increases the cleavage of cortical amyloid precursor protein. Suprisingly, AD mice with dysfunctional myelin lack plaque-corralling microglia despite an overall increase in their numbers. Bulk and single-cell transcriptomics of AD mouse models with myelin defects show that there is a concomitant induction of highly similar but distinct disease-associated microglia signatures specific to myelin damage and amyloid plaques, respectively. Despite successful induction, amyloid disease-associated microglia (DAM) that usually clear amyloid plaques are apparently distracted to nearby myelin damage. Our data suggest a working model whereby age-dependent structural defects of myelin promote Aβ plaque formation directly and indirectly and are therefore an upstream AD risk factor. Improving oligodendrocyte health and myelin integrity could be a promising target to delay development and slow progression of AD.

Date: 2023
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41586-023-06120-6 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:618:y:2023:i:7964:d:10.1038_s41586-023-06120-6

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-023-06120-6

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-22
Handle: RePEc:nat:nature:v:618:y:2023:i:7964:d:10.1038_s41586-023-06120-6